Home LiteratureArticle Details
PMID: 2120285 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Interferon-gamma overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages.

The Journal of clinical investigation ·Vol. 86 ·No. 4 ·1990-10-00 ·Pages 1234-40

Luedke CE, Cerami A

Abstract

Glucocorticoids almost completely inhibit the synthesis by isolated macrophages of cachectin/tumor necrosis factor (TNF), a cytokine implicated as a major endogenous mediator of septic shock. Despite this in vitro effectiveness, the clinical use of glucocorticoids has failed to demonstrate any clear benefit in the treatment of septic shock. In an effort to understand what other mechanisms might play a role in the patient with sepsis, we examined the effect of interferon-gamma (IFN gamma) on the synthesis of cachectin/TNF. We show here that IFN gamma, although unable by itself to induce cachectin/TNF synthesis, enhanced the endotoxin-induced production of cachectin/TNF in vitro. Furthermore, IFN gamma overcame the inhibition of cachectin/TNF synthesis caused by the glucocorticoid, dexamethasone. These effects of IFN gamma were accounted for by increased levels of cachectin/TNF mRNA. The in vivo implications of these studies are discussed with emphasis on their relevance in human sepsis.

MeSH Terms
Animals Cells, Cultured Dexamethasone/pharmacology Female Glucocorticoids/pharmacology Interferon-gamma/pharmacology Lipopolysaccharides/pharmacology Macrophages/drug effects,metabolism Mice Mice, Inbred C3H RNA, Messenger/analysis Tumor Necrosis Factor-alpha/biosynthesis,genetics
Chemicals
Glucocorticoids Lipopolysaccharides RNA, Messenger Tumor Necrosis Factor-alpha Dexamethasone Interferon-gamma
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Luedke C E
Labortory of Medical Biochemistry, Rockefeller University, New York 10021.
Cerami A
References (32)
32 references, click to expand
  1. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  2. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.
    N Engl J Med. 1988 Aug 18;319(7):397-400 PMID: 3135497
  3. Steroids in the treatment of clinical septic shock.
    Ann Surg. 1976 Sep;184(3):333-41 PMID: 786190
  4. Recovery from lethal Escherichia coli shock in dogs.
    Surg Gynecol Obstet. 1979 Oct;149(4):545-53 PMID: 39354
  5. Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples.
    J Biol Chem. 1982 Aug 10;257(15):8569-72 PMID: 7096324
  6. Evidence for the identity of murine gamma interferon and macrophage activating factor.
    J Interferon Res. 1982;2(4):519-32 PMID: 6815284
  7. Current management of the septic shock patient: experimental basis for treatment.
    Circ Shock. 1982;9(5):543-53 PMID: 6756669
  8. Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing.
    J Immunol. 1983 May;130(5):2011-3 PMID: 6403616
  9. Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.
    J Immunol. 1983 Aug;131(2):826-32 PMID: 6408190
  10. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
    J Exp Med. 1983 Sep 1;158(3):670-89 PMID: 6411853
  11. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.
    J Clin Invest. 1983 Oct;72(4):1506-10 PMID: 6415111
  12. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
    J Immunol Methods. 1983 Dec 16;65(1-2):55-63 PMID: 6606682
  13. Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin.
    J Exp Med. 1984 Mar 1;159(3):828-43 PMID: 6421983
  14. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.
    Nucleic Acids Res. 1984 Sep 25;12(18):7035-56 PMID: 6091052
  15. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):724-9 PMID: 6392892
  16. Human tumor necrosis factor. Production, purification, and characterization.
    J Biol Chem. 1985 Feb 25;260(4):2345-54 PMID: 3871770
  17. Activation of neonatal and adult human macrophages by alpha, beta, and gamma interferons.
    Infect Immun. 1985 Aug;49(2):351-6 PMID: 3926648
  18. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Science. 1985 Aug 30;229(4716):869-71 PMID: 3895437
  19. Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma.
    Cell Immunol. 1985 Sep;94(2):500-11 PMID: 3928173
  20. Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.
    J Immunol. 1985 Oct;135(4):2492-7 PMID: 3928750
  21. Cachectin and tumour necrosis factor as two sides of the same biological coin.
    Nature. 1986 Apr 17-23;320(6063):584-8 PMID: 3010124
  22. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.
    Science. 1986 May 23;232(4753):977-80 PMID: 3754653
  23. Shock and tissue injury induced by recombinant human cachectin.
    Science. 1986 Oct 24;234(4775):470-4 PMID: 3764421
  24. Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype.
    J Exp Med. 1986 Nov 1;164(5):1791-6 PMID: 3095481
  25. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.
    J Exp Med. 1986 Dec 1;164(6):2113-8 PMID: 3097240
  26. Cachectin: more than a tumor necrosis factor.
    N Engl J Med. 1987 Feb 12;316(7):379-85 PMID: 3543677
  27. In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.
    J Immunol. 1987 Apr 15;138(8):2457-62 PMID: 3104467
  28. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.
    N Engl J Med. 1987 Sep 10;317(11):653-8 PMID: 3306374
  29. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
    Nature. 1987 Dec 17-23;330(6149):662-4 PMID: 3317066
  30. Cytokine appearance in human endotoxemia and primate bacteremia.
    Surg Gynecol Obstet. 1988 Feb;166(2):147-53 PMID: 3122336
  31. Cachectin: a hormone that triggers acute shock and chronic cachexia.
    J Infect Dis. 1988 Mar;157(3):413-20 PMID: 3278061
  32. Glucocorticoid and antibiotic effect on experimental gram-negative bacteremic shock.
    Arch Surg. 1975 Aug;110(8):1012-5 PMID: 1100013
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1990-10-00
Pages
1234-40
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC296853
Subset
IM
Grants
NIAID NIH HHS · AI-21359 · United States
NIGMS NIH HHS · GM-07739 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]